title: Self-Assembled Cationic Biodegradable Nanoparticles from pH-Responsive Amino-Acid-Based Poly(Ester Urea Urethane)s and Their Application As a Drug Delivery Vehicle.
abstract: The objective of this study is to develop a new family of biodegradable and biologically active copolymers and their subsequent self-assembled cationic nanoparticles as better delivery vehicles for anticancer drugs to achieve the synergism between the cytotoxicity effects of the loaded drugs and the macrophage inflammatory response of the delivery vehicle. This family of cationic nanoparticles was formulated from a new family of amphiphilic cationic Arginine-Leucine (Arg-Leu)-based poly(ester urea urethane) (Arg-Leu PEUU) synthesized from four building blocks (amino acids, diols, glycerol α-monoallyl ether, and 1,6 hexamethylene diisocyanate). The chemical, physical, and biological properties of Arg-Leu PEUU biomaterials can be tuned by controlling the feed ratio of the four building blocks. The Arg-Leu PEUU copolymers have weight-average molecular weights from 13.4 to 16.8 kDa and glass-transition temperatures from -3.4 to -4.6 °C. The self-assembled cationic nanoparticles (Arg-Leu PEUU NPs) were prepared using a facile dialysis method. Arg-Leu PEUU NPs have average diameters ranging from 187 to 272 nm, show good biocompatibility with 3T3 fibroblasts, and they support bovine aortic endothelial cell (BAEC) proliferation and adhesion. Arg-Leu PEUU NPs also enhanced the macrophages' production of tumor necrosis factor-α (TNF-α) and nitric oxide (NO), but produced relatively low levels of interleukin-10 (IL-10), and therefore, the antitumor activity of macrophages might be enhanced. Arg-Leu PEUU NPs were taken up by HeLa cells after 4 h of incubation. The in vitro hemolysis assay showed the cationic Arg-Leu PEUU NPs increased their chance of endosomal escape at a more acidic pH. Doxorubicin (DOX) was successfully incorporated into the Arg-Leu PEUU NPs, and the DOX-loaded Arg-Leu PEUU NPs exhibited a pH-dependent drug release profile with accelerated release kinetics in a mild acidic condition. The DOX-loaded 6-Arg-4-Leu-4 A/L-2/1 NPs showed higher HeLa cell toxicity than the free DOX at the same concentration after 24 h of treatment. The results suggest the cationic Arg-Leu PEUU NPs could potentially be a useful carrier family for hydrophobic anticancer drugs and produce a synergistic effect between DOX cytotoxicity and the production of TNF-α and NO by macrophages.
authors.affiliation: Department of Fiber Science and Apparel Design, Cornell University , Ithaca, New York 14853-4401, United States.
authors.forename: Mingyu
authors.initials: M
authors.lastname: He
authors.affiliation: Department of Chemistry and Chemical Biology, Cornell University , Ithaca, New York 14853, United States.
authors.forename: Alicia
authors.initials: A
authors.lastname: Potuck
authors.affiliation: Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University , Ithaca, New York 14853, United States.
authors.forename: Julie C
authors.initials: JC
authors.lastname: Kohn
authors.affiliation: Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University , Ithaca, New York 14853, United States.
authors.forename: Katharina
authors.initials: K
authors.lastname: Fung
authors.affiliation: Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University , Ithaca, New York 14853, United States.
authors.forename: Cynthia A
authors.initials: CA
authors.lastname: Reinhart-King
authors.affiliation: Department of Fiber Science and Apparel Design, Cornell University , Ithaca, New York 14853-4401, United States.
authors.forename: Chih-Chang
authors.initials: CC
authors.lastname: Chu
mesh_terms: D016475:3T3 Cells; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D001120:Arginine / Q000737:chemistry; D002412:Cations; D002417:Cattle; D002448:Cell Adhesion; D004317:Doxorubicin / Q000737:chemistry* / Q000378:metabolism / Q000494:pharmacology; D004337:Drug Carriers / Q000737:chemistry*; D004339:Drug Compounding; D004354:Drug Screening Assays, Antitumor; D006367:HeLa Cells; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007930:Leucine / Q000737:chemistry; D051379:Mice; D053758:Nanoparticles / Q000737:chemistry*; D011091:Polyesters / Q000737:chemistry*; D058105:Polymerization; D000067996:RAW 264.7 Cells; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D000903:Antibiotics, Antineoplastic; D002412:Cations; D004337:Drug Carriers; D011091:Polyesters; D014409:Tumor Necrosis Factor-alpha; C497893:poly(ester urethane)urea; D004317:Doxorubicin; D001120:Arginine; D007930:Leucine